http://rdf.ncbi.nlm.nih.gov/pubchem/patent/HU-0700411-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f9a36328274867f46f8fc1fb9c868703
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D281-16
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D281-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-04
filingDate 2007-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b8d749b1c9a4a02fdad42390ec7412f9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c78c42f22fbcf119cf205ab22e5df1c7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7e7058a248d346c7d74d9426fdcbf3fd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f06d6225ca53cda84b4a038af365c11
publicationDate 2009-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber HU-0700411-A2
titleOfInvention Process for producing quetiapine
abstract Process for the synthesis of 2-[2-(4-dibenzo[b,f][1,4]thiazepine-11-yl-piperazine-1-yl)-ethoxy]-ethanol of formula (I) (quetiapine) by reacting the 1-oxodibenzo-[b,f][1,4]thiazepine of formula (II) with phosphorus oxychloride by d) using 1-6 molequivalent of phosphorus oxychloride in an inert solvent and the obtained 11-chlorodibenzo[b,f][1,4]thiazepine compound of formula (IV) without isolation; e) is reacted further in an inert solvent in the presence of a base with 2-[2-(1-piperazinyl)-ethoxy]-ethanol dihydrochloride of formula (III a) or dihydrochloride monohydrate of formula (III b), in the mixture of an inert non-polar and dipolar aprotic solvent; f) in desired case the isolated quetiapine base of formula (I) is reacted with fumaric acid to form the hemifumarate salt thereof.
priorityDate 2007-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID679
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444972
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID428119048
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454531723
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69175532
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID374829
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID145528872
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID76939
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3020606
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID160264754
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12444278
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419520253
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24813
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419498309
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154960504
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415954435
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449898910
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538066
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546200
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474096
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419544909
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID139436
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419780273
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452107106
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451834283
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16351
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5002
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21226127
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7964
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492896
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450338026
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419524391

Total number of triples: 47.